Ligand Pharmaceuticals Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2015-03-31 3 months ending 2014-12-31 3 months ending 2014-09-30 6 months ending 2014-06-30 3 months ending 2014-03-31
Revenue 14.60 23.00 14.97 26.57 15.96
Other Revenue, Total - - - - -
Total Revenue 14.60 23.00 14.97 26.57 15.96
Cost of Revenue, Total 1.07 4.00 1.50 3.64 2.45
Gross Profit 13.53 19.00 13.48 22.93 13.51
Selling/General/Admin. Expenses, Total 5.99 5.52 6.74 10.31 5.07
Research & Development 3.96 3.28 3.02 5.82 3.13
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) 0.22 0.56 0.18 0.34 0.20
Other Operating Expenses, Total - - - - -
Total Operating Expense 11.25 13.36 11.44 20.11 10.86
Operating Income 3.35 9.64 3.53 6.46 5.10
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net -0.45 0.29 -1.11 -2.64 -2.70
Income Before Tax -0.07 7.01 0.90 3.39 2.15
Income After Tax -0.09 6.73 0.78 3.38 2.10
Minority Interest 0.84 0.32 0.50 0.31 0.00
Equity In Affiliates - - - - -
Net Income Before Extra. Items 0.75 7.05 1.28 3.69 2.10
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income 0.75 7.05 1.28 3.69 2.10
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items 0.75 7.05 1.28 3.69 2.10
Income Available to Common Incl. Extra Items 0.75 7.05 1.28 3.69 2.10
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment 0.07 - - - 0.00
Diluted Weighted Average Shares 20.63 20.84 21.35 21.49 21.78
Diluted EPS Excluding Extraordinary Items 0.04 0.34 0.06 0.17 0.10
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 - 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS 0.05 0.36 0.07 0.19 0.11